Therapeutic Efficacy in Women With Stress Urinary Incontinence

NCT05677295 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2023-05-19

No results posted yet for this study

Summary

We will get the impact of duloxetine versus imipramine on therapeutic efficacy in women with SUI.

Conditions

  • Women With Stress Urinary Incontinence

Interventions

DRUG

duloxetine

Duloxetine 30 mg per day

DRUG

Imipramine

Imipramine 25 mg per day

Sponsors & Collaborators

  • Far Eastern Memorial Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
25 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-18
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05677295 on ClinicalTrials.gov